GO
Loading...

Johnson & Johnson

More

  • Midday Glance: Pharmaceuticals companies Friday, 19 Sep 2014 | 1:33 PM ET

    Baxter International Inc. fell$. 59 or. 8 percent, to $72.51. Bristol-Myers Squibb Co. rose$. 44 or. 9 percent, to $51.56. Hospira rose$. 39 or. 7 percent, to $53.90.

  • Midday Glance: Medical Devices companies Friday, 19 Sep 2014 | 1:33 PM ET

    Allergan fell $2.45 or 1.4 percent, to $167.52. Baxter International Inc. fell$. 59 or. 8 percent, to $72.51. Boston Scientific Corp. fell$. 11 or. 9 percent, to $12.31.

  • Early Glance: Pharmaceuticals companies Friday, 19 Sep 2014 | 10:16 AM ET

    Baxter International Inc. fell$. 38 or. 5 percent, to $72.72. Bristol-Myers Squibb Co. rose$. 42 or. 8 percent, to $51.54. Hospira rose$. 38 or. 7 percent, to $53.89.

  • Early Glance: Medical Devices companies Friday, 19 Sep 2014 | 10:16 AM ET

    Allergan fell $1.01 or. 6 percent, to $168.96. Baxter International Inc. fell$. 38 or. 5 percent, to $72.72. Boston Scientific Corp. fell$. 01 or. 1 percent, to $12.41.

  • Final Glance: Medical Devices companies Thursday, 18 Sep 2014 | 6:04 PM ET

    Allergan fell$. 07 or percent, to $169.97. Baxter International Inc. rose$. 45 or. 6 percent, to $73.10. Boston Scientific Corp. rose$. 20 or 1.6 percent, to $12.42.

  • Final Glance: Pharmaceuticals companies Thursday, 18 Sep 2014 | 6:04 PM ET

    Baxter International Inc. rose$. 45 or. 6 percent, to $73.10. Bristol-Myers Squibb Co. rose$. 24 or. 5 percent, to $51.12. Hospira rose$. 07 or. 1 percent, to $53.51.

  • Midday Glance: Medical Devices companies Thursday, 18 Sep 2014 | 1:18 PM ET

    Allergan fell$. 42 or. 2 percent, to $169.62. Baxter International Inc. rose$. 36 or. 5 percent, to $73.01. Boston Scientific Corp. rose$. 26 or 2.1 percent, to $12.48.

  • Midday Glance: Pharmaceuticals companies Thursday, 18 Sep 2014 | 1:18 PM ET

    Baxter International Inc. rose$. 36 or. 5 percent, to $73.01. Bristol-Myers Squibb Co. rose$. 32 or. 6 percent, to $51.20. Hospira rose$. 24 or. 4 percent, to $53.68.

  • INSIGHT-A year later, most mega IPOs are mega laggards Thursday, 18 Sep 2014 | 1:06 PM ET

    NEW YORK, Sept 18- If history is any guide, investors who miss out on getting a slice of Alibaba's massive initial public offering may want to think twice about jumping into the stock once it hits the New York Stock Exchange.

  • Final Glance: Medical Devices companies Wednesday, 17 Sep 2014 | 6:04 PM ET

    Allergan fell$. 16 or. 1 percent, to $170.04. Baxter International Inc. fell $2.34 or 3.1 percent, to $72.65. Boston Scientific Corp. fell$. 12 or 1.0 percent, to $12.22.

  • Final Glance: Pharmaceuticals companies Wednesday, 17 Sep 2014 | 6:04 PM ET

    Baxter International Inc. fell $2.34 or 3.1 percent, to $72.65. Bristol-Myers Squibb Co. fell$. 27 or. 5 percent, to $50.88. Hospira rose$. 19 or. 4 percent, to $53.44.

  • Midday Glance: Pharmaceuticals companies Wednesday, 17 Sep 2014 | 1:17 PM ET

    Baxter International Inc. fell $2.17 or 2.9 percent, to $72.82. Johnson& Johnson rose$. 01 or percent, to $105.89. Eli Lilly& Co. rose$. 01 or percent, to $65.81.

  • Midday Glance: Medical Devices companies Wednesday, 17 Sep 2014 | 1:17 PM ET

    Allergan fell$. 47 or. 3 percent, to $169.73. Baxter International Inc. fell $2.17 or 2.9 percent, to $72.82. Boston Scientific Corp. rose$. 06 or. 4 percent, to $12.40.

  • Early Glance: Pharmaceuticals companies Wednesday, 17 Sep 2014 | 10:29 AM ET

    Baxter International Inc. fell $1.33 or 1.8 percent, to $73.66. Bristol-Myers Squibb Co. fell$. 16 or. 3 percent, to $50.99. Hospira rose$. 09 or. 2 percent, to $53.34.

  • Early Glance: Medical Devices companies Wednesday, 17 Sep 2014 | 10:29 AM ET

    Allergan rose$. 10 or. 1 percent, to $170.30. Baxter International Inc. fell $1.33 or 1.8 percent, to $73.66. Boston Scientific Corp. rose$. 08 or. 6 percent, to $12.42.

  • WASHINGTON, Sept 16- Leaders of some of the biggest U.S. corporations, from Coca-Cola Co to Johnson& Johnson, unveiled a campaign on Tuesday to reduce the nation's healthcare costs, urging their peers to embrace wellness programs to improve employee health.

  • WASHINGTON, Sept 16- Leaders of some of the biggest U.S. corporations, from Coca-Cola Co to Johnson& Johnson, unveiled a campaign on Tuesday to reduce the nation's healthcare costs, urging their peers to embrace wellness programs to improve employee health.

  • Sept 15- Epirus Biopharmaceuticals Inc said India's drug regulator has approved its copy of a top-selling arthritis treatment, paving the way for its launch in the country early next year.

  • LOS ANGELES, Sept 12- The next generation version of Gilead Sciences Inc's $84,000 hepatitis C drug, already under fire for its record-breaking costs, is going to be even more expensive.

  • *BAT unit working with Kind Consumer, Consort Medical. LONDON, Sept 12- A new nicotine inhaler to be sold by British American Tobacco has been licensed in the UK as a medicinal product, marking the arrival of a novel alternative to the fast-growing market for electronic cigarettes.